No Prescription

Proctofoam HC GB Hydrocortisone acetate

No Prescription » Prescription Drugs 13 » Proctofoam HC GB Hydrocortisone acetate

Proctofoam-HC« is mucoadhesive analgesic and anti-inflammatory foam prescribed by health professionals for the relief of anorectal inflammation and swelling associated with hemorrhoids pruritus ani anal fissures and other anorectal discomforts.This unique metered-dose aerosol foam is particularly effective for the relief of postpartum hemorrhoids affecting as many as 3 out of 4 natural childbirthing women.In addition to bringing fast and effective relief of pain inflammation and itching Proctofoam-HC« provides many advantages over suppositories or ointments:It is gentle clean to apply and highly sanitary: there is no need to touch the affected area Due to its mucoadhesive properties the foam spreads quickly to the inflamed area and stays in place without leaking A small amount covers a large area. At least 36 applications are contained in a single unit of Proctofoam-HC making it the most economic treatment available. Its metered-dosing internal and external applicators are easy to fill convenient to use and easy to keep clean. A simple topical application provides immediate relief of pain inflammation and itching without the risk of caine-like sensitization and without staining clothing.

Buy Proctofoam HC GB Hydrocortisone acetate and other Prescription Drugs 13 products online at Medstore.

Buy Online at Medstore - Click Here!

About Proctofoam HC GB Hydrocortisone acetate:

Product Type: Prescription Drugs 13

Proctofoam HC (GB) ( Hydrocortisone acetate + Pramocaine ) Product Origin: United Kingdom

Proctofoam HC (GB Hydrocortisone acetate + Pramocaine)

GB Hydrocortisone acetate + Pramocaine

1%/1%w/w GB Hydrocortisone acetate + Pramocaine Proctofoam HC

View more Prescription Drugs 13

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.